SVB Leerink Maintains Outperform on Axsome Therapeutics, Raises Price Target to $75

SVB Leerink analyst Marc Goodman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $50 to $75.

SVB Leerink analyst Marc Goodman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $50 to $75.

Total
0
Shares
Related Posts